Related Experiment Video
Updated: Jun 26, 2026
05:35
Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
Published on: June 23, 2018
Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas
Alexander Fort1, Nicholas Fort, Camillo Ricordi
1Diabetes Research Institute, University of Miami, Miami, FL 33136, USA.
Cell Transplantation
|January 31, 2009
Summary
Cell-based therapies show promise for metabolic organ treatments, offering natural glycemic control for type 1 diabetes. Advances in biohybrid devices and encapsulation improve cell survival, overcoming transplantation challenges.
Area of Science:
- Regenerative medicine and cell therapy for metabolic disorders.
- Bioengineering and biomaterials for tissue engineering.
- Endocrinology and diabetes mellitus research.
Background:
- Cell-based treatments, especially pancreatic islet transplantation, are advancing for type 1 diabetes mellitus (T1DM).
- Islet transplantation aims to restore natural glycemic control and prevent hypoglycemia unawareness.
- Current transplantation methods face challenges including inflammation, vascularization issues, immunosuppression needs, and graft stress.
Purpose of the Study:
- To review recent advancements in cell-based therapies for metabolic organs, focusing on the pancreas.
- To highlight challenges associated with current islet transplantation techniques.
- To explore novel biohybrid devices and encapsulation technologies as alternative solutions.
Main Methods:
- Review of current literature on cell-based therapies for T1DM.
- Analysis of challenges in islet transplantation to the liver portal vein.
- Investigation of emerging bioengineering and encapsulation strategies.
Main Results:
- Cellular therapies offer potential for improved glycemic management in T1DM.
- Islet cell transplantation faces significant hurdles impacting graft survival.
- Engineered biohybrid devices and encapsulation show promise in addressing these challenges.
Conclusions:
- New biohybrid devices and encapsulation technologies represent promising alternatives for pancreatic islet transplantation.
- These innovations aim to enhance cell survival and overcome limitations of current therapeutic approaches.
- Further research in bioengineering is crucial for advancing cell-based treatments for metabolic diseases.
